Patent ID: 9248186
Filing Date: 2016-02-02
CPC Classification: A61K,A61P

Claim Text:
1. A method for treating epistaxis in a human, said method comprising a step of administering to a human patient suffering from epistaxis an effective amount of a composition comprising 0.4-1.3 ml of 0.05% oxymetazoline aqueous solution per 1 gram of bismuth subgallate powder, said composition being effective for treating epistaxis in a human when administered to a human patient suffering from epistaxis, said bismuth subgallate being present in said composition in a weight percent effective to assist in slowing or stopping epistaxis, said oxymetazoline being present in said composition in a weight percent effective to assist in slowing or stopping epistaxis, said weight percent of bismuth subgallate and said weight percent of said oxymetazoline being effective, in combination, to treat epistaxis when said composition is administered to a human patient suffering from epistaxis.